• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Healthcare Businesswomen's Association recognizes Delix Therapeutics and Pfizer UK


The companies have shown a commitment to enhancing greater equity for women.

To showcase the impactful commitment and outcomes of equitable practices for women in the workplace, the Healthcare Businesswomen’s Association (HBA) recognizes Delix Therapeutics and Pfizer UK Ltd., for initiatives working to close the gender gap in the healthcare and life science industries. The awards will be presented on Thursday, November 3, in conjunction with HBA’s Annual Conference in Philadelphia.

HBA’s Advancement. Commitment. Engagement. (ACE) Awards recognize companies committed to ensuring that gender diversity and leadership opportunities for women are part of their organizational DNA. An independent panel of healthcare industry leaders selects ACE Award recipients for their excellence in advancing their female talent and removing the systemic barriers preventing timely progress to parity. Award criteria include measurable results, business performance, stewardship, execution, and sustainability.

Read more here.

Recent Videos
Related Content